Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Investigating paralogue-specific roles of chromatin remodeling in liver fibrosis

EF 2025-26

Résumé
Liver scarring underlies a global health concern, contributing to nearly 2 million deaths annually. Scarring (also known as fibrosis) occurs when cells in the liver become activated and secrete copious amounts of scar tissue, creating a favorable environment for the development of more severe diseases such as cirrhosis and liver cancers. While we know a lot about the signals that trigger fibrosis, we still don't fully understand how changes in liver cells, specifically changes in how their DNA is organized and expressed, contribute to fibrosis. In human cells, DNA is coiled around proteins known as nucleosomes. This packaging influences which genes are turned on or off at specific times. Protein complexes like the SWI/SNF complex can remodel this packaging through their ability to move nucleosomes out of the way. Two key related proteins found in the complex, BRG1 and BRM, have been shown to have opposing effects in fibrosis: with BRG1 promoting liver fibrosis and BRM preventing it. However, the mechanism by which they influence fibrosis remain unclear, and we currently lack methods to target BRG1 therapeutically. My project aims to define the roles of BRG1 and BRM in liver fibrosis and develop new therapeutic approaches to target BRG1. I will use genetic approaches in human liver organoids to study the changes in DNA packaging during fibrosis and investigate the specific contribution of BRG1 and BRM to these changes. Ultimately, my project will inform development of antifibrotic therapies that have a considerable effect on patient outcomes by preventing end stage diseases like cirrhosis and liver cancer, both of which have high mortality rates and limited treatment options.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
556177
Name
Mazarura Grace R
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Genetics
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Investigating paralogue-specific roles of chromatin remodeling in liver fibrosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Brg1/Brm; Chromatin Remodellers; Epigentics; Fibrosis; Hepatic Organoids; Hepatic Stellate Cells; Liver Fibrosis; Rnaseq/Atacseq; Spatial Transcriptomics; Swi/Snf
Abstract
Liver scarring underlies a global health concern, contributing to nearly 2 million deaths annually. Scarring (also known as fibrosis) occurs when cells in the liver become activated and secrete copious amounts of scar tissue, creating a favorable environment for the development of more severe diseases such as cirrhosis and liver cancers. While we know a lot about the signals that trigger fibrosis, we still don't fully understand how changes in liver cells, specifically changes in how their DNA is organized and expressed, contribute to fibrosis. In human cells, DNA is coiled around proteins known as nucleosomes. This packaging influences which genes are turned on or off at specific times. Protein complexes like the SWI/SNF complex can remodel this packaging through their ability to move nucleosomes out of the way. Two key related proteins found in the complex, BRG1 and BRM, have been shown to have opposing effects in fibrosis: with BRG1 promoting liver fibrosis and BRM preventing it. However, the mechanism by which they influence fibrosis remain unclear, and we currently lack methods to target BRG1 therapeutically. My project aims to define the roles of BRG1 and BRM in liver fibrosis and develop new therapeutic approaches to target BRG1. I will use genetic approaches in human liver organoids to study the changes in DNA packaging during fibrosis and investigate the specific contribution of BRG1 and BRM to these changes. Ultimately, my project will inform development of antifibrotic therapies that have a considerable effect on patient outcomes by preventing end stage diseases like cirrhosis and liver cancer, both of which have high mortality rates and limited treatment options.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mazarura, Grace R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~